The Investor Relation function at SSO seeks to communicate with existing and potential investors such as Financial Institutions, Foreign Institutional Investors, Mutual Management Companies and provides the investment community with periodical information on the company's business operations and important financial information.This column facilitates its investors to take informed decisions on their investment options.

Company Secretary & Compliance Officer

Ms. Kumkum Bajaj
Company Secretary and Compliance Officer
Oxygenta Pharmaceutical Limited.

Registered Office: Survey No.252/1,
Aroor village,sadasivapet mandal,
Medak District, Medak,
Telangana, India, 502291.

Corporate office:Level-1 Plot No B1 and B2,
IDA Gandhi Nagar, Balanagar Township,
Hyderabad, Rangareddy,
Telangana, India, 500037
Email: cs@oxygentapharma.com

Registrar and Transfer Agent(RTA)

Address for investor correspondence for queries on shares
Mrs. Radha Nagarajan

Venture Capital and Corporate Investments Private Limited
AURUM, 4th & 5th Floors, Plot No.57,
Jayabheri Enclave, Phase – II,
Gachibowli, Hyderabad – 500032,
e-mail : info@vccipl.com , online@vccipl.com, radhanagarajan@vccipl.com
Contact: 040-23818475/76